TG and ovarian cancer: In cancer, changes in circulating levels of thyroid hormones due to thyroid disease and/or altered tumour expression of their receptors may impact tumour growth, invasion, and metastatic potential, and this has been reported in several cancer types, including glioma, myeloma, breast, lung and ovarian cancer [7].